TAKARA BIO INC. is a biopharmaceutical company.  The Company researches and develops reagents for genome engineering and analysis, technology used for gene therapy, and natural health food products using mushrooms and seaweed body and extracts.

Consolidated Financial Results For The Three Months Ended June 30, 2024 (Under Japanese Gaap)

[Delayed] Annual Securities Report For Fiscal Year Ended March 31, 2024

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Takara Bio Inc (4974 JP)

Consolidated Financial Results For The Three Months Ended June 30, 2024 (Under Japanese Gaap)

[Delayed] Annual Securities Report For Fiscal Year Ended March 31, 2024

Matters Concerning Controlling Shareholders

Consolidated Financial Results For The Fiscal Year Ended March 31, 2024 (Under Japanese Gaap)

Notice Concerning Dividends From Surplus

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)